{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:00:08Z","timestamp":1790226008538,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"crossref","award":["CE16241B"],"award-info":[{"award-number":["CE16241B"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222860","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:46:22Z","timestamp":1568915182000},"page":"e0222860","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study"],"prefix":"10.1371","volume":"14","author":[{"given":"Hsin-Hua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Yi","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Da","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-6448","authenticated-orcid":true,"given":"Chien-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,19]]},"reference":[{"key":"pone.0222860.ref001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","article-title":"Sex-andage-specific incidence of autoimmune rheumatic diseases in the Chinese population: A Taiwan population-based study","volume":"43","author":"LC See","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"pone.0222860.ref002","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12253-010-9256-8","article-title":"Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer","volume":"16","author":"M Jaberipour","year":"2010","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"pone.0222860.ref003","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/156800910793605811","article-title":"New insights of CTLA-4 into its biological function in breast cancer","volume":"10","author":"H Mao","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"issue":"11","key":"pone.0222860.ref004","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.31557\/APJCP.2018.19.11.3019","article-title":"Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer","volume":"19","author":"E Khalife","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"pone.0222860.ref005","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid","volume":"50","author":"JM Van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"pone.0222860.ref006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells","volume":"35","author":"C Scheinecker","year":"2010","journal-title":"Journal of Autoimmunity"},{"key":"pone.0222860.ref007","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10753-016-0470-8","article-title":"Foxp3, Regulatory T Cell, and Autoimmune Diseases","volume":"40","author":"JH Tao","year":"2017","journal-title":"Inflammation"},{"key":"pone.0222860.ref008","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","article-title":"Th17 cells play a critical role in the development of experimental Sj\u00f6gren's syndrome","volume":"74","author":"X Lin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"pone.0222860.ref009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/BOR.0000000000000473","article-title":"Current views on the pathogenesis of Sj\u00f6gren's syndrome","volume":"30","author":"E Pontarini","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"pone.0222860.ref010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","article-title":"Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy","volume":"53","author":"P Venalis","year":"2014","journal-title":"Rheumatology"},{"key":"pone.0222860.ref011","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and lymyositis are dominated by CD28null T cells","volume":"183","author":"AE Fasth","year":"2009","journal-title":"J Immunol"},{"key":"pone.0222860.ref012","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpdd.251","article-title":"Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients","volume":"5","author":"T Zhu","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"key":"pone.0222860.ref013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/annrheumdis-2017-211751","article-title":"Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial","volume":"77","author":"A Tjarnlund","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"pone.0222860.ref014","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"PJ Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"pone.0222860.ref015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: A Review in Rheumatoid Arthritis","volume":"77","author":"HA Blair","year":"2017","journal-title":"Drugs"},{"key":"pone.0222860.ref016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"WH Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"pone.0222860.ref017","first-page":"615","article-title":"Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China","volume":"32","author":"D Chen","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"pone.0222860.ref018","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"B Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"key":"pone.0222860.ref019","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"CF Kuo","year":"2011","journal-title":"Br J Dermatol"},{"key":"pone.0222860.ref020","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"35","author":"YF Fang","year":"2016","journal-title":"Clin Rheumatol"},{"key":"pone.0222860.ref021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan's new National Health Insurance program: genesis and experience so far","volume":"22","author":"TM Cheng","year":"2003","journal-title":"Health Aff (Millwood)"},{"key":"pone.0222860.ref022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"RA Deyo","year":"1992","journal-title":"J clin epidemiol"},{"key":"pone.0222860.ref023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"J Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0222860.ref024","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"ED Kwon","year":"2014","journal-title":"Lancet Oncol"},{"key":"pone.0222860.ref025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies","volume":"249","author":"GJ Hengstman","year":"2002","journal-title":"J Neurol"},{"key":"pone.0222860.ref026","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"C Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"pone.0222860.ref027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"AG Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"pone.0222860.ref028","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"LA Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"pone.0222860.ref029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","article-title":"Novel autoantibodies and clinical phenotypes in adult and juvenile myositis","volume":"13","author":"ZE Betteridge","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"pone.0222860.ref030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","article-title":"Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy","volume":"109","author":"SA Rutjes","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"pone.0222860.ref031","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"A Selva-O\u2019Callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"pone.0222860.ref032","first-page":"71","article-title":"Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease","volume":"35","author":"AA Shah","year":"2017","journal-title":"Clin Exp Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:58:46Z","timestamp":1588964326000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222860"}},"subtitle":[],"editor":[{"given":"Pirkko L.","family":"H\u00e4rk\u00f6nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,19]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222860","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,19]]}}}